From the Department of Preventive Medicine and Biostatistics (A.I.S.), Uniformed Services University, Bethesda, MD; and Department of Neurology (P.B.R., E.W.L.), Brigham and Women's Hospital, Boston, MA.
Neurology. 2017 Sep 19;89(12):1296-1304. doi: 10.1212/WNL.0000000000004371. Epub 2017 Aug 18.
It is a widely accepted idea that medications taken to relieve acute headache pain can paradoxically worsen headache if used too often. This type of secondary headache is referred to as medication overuse headache (MOH); previously used terms include rebound headache and drug-induced headache. In the absence of consensus about the duration of use, amount, and type of medication needed to cause MOH, the default position is conservative. A common recommendation is to limit treatment to no more than 10 or 15 days per month (depending on medication type) to prevent headache frequency progression. Medication withdrawal is often recommended as a first step in treatment of patients with very frequent headaches. Existing evidence, however, does not provide a strong basis for such causal claims about the relationship between medication use and frequent headache. Observational studies linking treatment patterns with headache frequency are by their nature confounded by indication. Medication withdrawal studies have mostly been uncontrolled and often have high dropout rates. Evaluation of this evidence suggests that only a minority of patients required to limit the use of symptomatic medication may benefit from treatment limitation. Similarly, only a minority of patients deemed to be overusing medications may benefit from withdrawal. These findings raise serious questions about the value of withholding or withdrawing symptom-relieving medications from people with frequent headaches solely to prevent or treat MOH. The benefits of doing so are smaller, and the harms larger, than currently recognized. The concept of MOH should be viewed with more skepticism. Until the evidence is better, we should avoid dogmatism about the use of symptomatic medication. Frequent use of symptom-relieving headache medications should be viewed more neutrally, as an indicator of poorly controlled headaches, and not invariably a cause.
人们普遍认为,用于缓解急性头痛的药物如果使用过于频繁,反而会使头痛恶化。这种继发性头痛被称为药物过度使用性头痛(MOH);以前使用的术语包括反弹性头痛和药物性头痛。由于对导致 MOH 所需的用药持续时间、用量和类型没有达成共识,因此默认立场是保守的。一个常见的建议是将治疗时间限制在每月不超过 10 或 15 天(取决于药物类型),以防止头痛频率进展。药物戒断通常被推荐作为治疗非常频繁头痛患者的第一步。然而,现有证据并没有为药物使用与频繁头痛之间的因果关系提供强有力的依据。将治疗模式与头痛频率联系起来的观察性研究本质上受到指示的影响。药物戒断研究大多是非对照的,并且经常有很高的脱落率。对这些证据的评估表明,只有少数需要限制使用对症药物的患者可能从治疗限制中受益。同样,只有少数被认为过度使用药物的患者可能从戒断中受益。这些发现对仅仅为了预防或治疗 MOH 而从频繁头痛患者中扣留或撤回缓解症状的药物的价值提出了严重质疑。这样做的好处较小,而危害更大,这比目前认识到的要大。应该更加怀疑 MOH 的概念。在证据更好之前,我们应该避免对对症药物的使用持教条主义态度。频繁使用缓解头痛的药物应更中立地看待,作为头痛控制不佳的指标,而不是一成不变的原因。